METTL3 and cancer: N6-methyladenosine (m6A) is the most abundant RNA base modification in mammalian mRNAs, especially in eukaryotic mRNA (7), and METTL3 is the core methyltransferase of m6A modification, which plays a critical biological role in the occurrence and development of various malignant tumors by regulating gene expression.